NorthWest Biotherapeutics Inc (NWBO)

[beachhyena]

My thinking is that the next article he writes on NWBO is where he will try to save face. He will point out that without acceptance of the new endpoints the trial would have failed and therefore his original assertion that the trial failed was correct. He will then reflect that now that the new endpoints have been accepted that the trial will now succeed. He will point out the failures of the original design but accept that because of the changing landscape with immunotherapies that OS was the only way to measure this particular trial.
I fully expect that the cabal that had earmarked failure with this trial are now covering and extending their long positions.
I do not expect any sharp down terms but upward mobility once the covering at these low prices is complete.
Just my opinion on where we stand with AF and his backers. Just remember money talks and all the talk will now be on the potential of the upside not the downside.